Merck (MRK) Other Non-Current Liabilities (2016 - 2025)
Merck (MRK) has disclosed Other Non-Current Liabilities for 16 consecutive years, with $7.7 billion as the latest value for Q4 2025.
- Quarterly Other Non-Current Liabilities rose 18.92% to $7.7 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $7.7 billion through Dec 2025, up 18.92% year-over-year, with the annual reading at $7.7 billion for FY2025, 18.92% up from the prior year.
- Other Non-Current Liabilities for Q4 2025 was $7.7 billion at Merck, roughly flat from $7.7 billion in the prior quarter.
- The five-year high for Other Non-Current Liabilities was $9.7 billion in Q1 2022, with the low at $208.0 million in Q3 2024.
- Average Other Non-Current Liabilities over 5 years is $3.4 billion, with a median of $847.5 million recorded in 2021.
- The sharpest move saw Other Non-Current Liabilities plummeted 97.17% in 2024, then surged 3583.17% in 2025.
- Over 5 years, Other Non-Current Liabilities stood at $777.0 million in 2021, then skyrocketed by 971.17% to $8.3 billion in 2022, then plummeted by 95.75% to $354.0 million in 2023, then skyrocketed by 1726.27% to $6.5 billion in 2024, then grew by 18.92% to $7.7 billion in 2025.
- According to Business Quant data, Other Non-Current Liabilities over the past three periods came in at $7.7 billion, $7.7 billion, and $7.0 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.